通过RNF7介导的ROS向不同IDH1基因型的质瘤中的恶性表型和放射治疗敏感性
Yiran Tao1,2, Zimin Shi1,2, Xianyin Liang1,2
1Department of Neurosurgery, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, The People's Republic of China.
Molecular carcinogenesis
|January 9, 2025
概括
环指蛋白7 (RNF7) 在质瘤中高度表达,通过缓冲氧化应激,在IDH1-突变瘤中促进恶性表型和辐射抵抗. RNF7可以作为一种关键的生物标志物,用于结质瘤治疗反应.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 环指蛋白7 (RNF7) 是Cullin-RING类型E3泛素酶 (CRL) 的组成部分,并具有内在的抗氧化特性.
- 异常的RNF7表达与瘤发生有关,但其在质母细胞瘤中的特定作用,特别是关于异酸脱酶 (IDH) 突变的作用,还不清楚.
- IDH突变驱动着质瘤中的代谢重编程,导致显著的基因型异质性.
研究的目的:
- 研究RNF7在质母细胞瘤中的作用和预后意义.
- 阐明RNF7在IDH1-突变性质瘤恶性表型和治疗耐药性的功能参与.
- 探索RNF7,氧还原平衡和对放射治疗的反应之间的关系.
主要方法:
- 对公共质瘤数据库的分析,以评估RNF7表达及其与不同IDH基因型患者预后和治疗结果的相关性.
- 在质瘤中对RNF7的功能丰富分析.
- 在体外细胞实验中验证RNF7在氧化还原平衡和对氧化应激和辐射的反应中的作用.
主要成果:
- 在质瘤中,RNF7的表达很高,与患者预后较差相关.
- 在不同的IDH基因型和治疗方式中,RNF7表达及其预后相关性各不相同.
- 在IDH1-突变性质瘤的恶性表型中,RNF7发挥着关键作用,通过维持氧化还原平衡和缓冲ROS诱导的氧化应激,为辐射耐药性做出贡献.
- 在放射后和IDH1-突变性质瘤中,RNF7的上调调节是由ROS诱导的.
结论:
- 在IDH1-突变质瘤中,RNF7是恶性表型和辐射耐药性的关键驱动因素.
- RNF7的抗ROS活性对于维持氧化还原平衡和赋予对氧化应激的代谢弹性至关重要.
- RNF7作为一个潜在的分子生物标志物用于预测质瘤放射敏感性和治疗结果.
相关概念视频
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
01:03Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K